#ai drug discovery
Discover 3 curated intelligence briefings related to this specific topic.
The Cytokine Storm in the Skull: Systemic Inflammation and the Dementia Pivot
C-reactive protein levels above 3 mg/L are no longer just markers of acute infection; they are now recognized as predictors of accelerated cognitive atrophy. The medical establishment spent decades chasing plaques while the house was burning down from the inside.
Silicon Models Cannot Solve Somatic Chaos
AI-driven drug discovery treats biological data as a clean signal, yet somatic mutations and biological age variance create a level of noise that current algorithms cannot parse. From the 156-year human lifespan cap to the chemical mixtures in pediatric cohorts, the gap between digital prediction and clinical reality is widening.
Generative Chemistry Just Broke the Lab Bottleneck
The surge in de novo molecular design, powered by $400M infusions and quantum-enhanced AI, has created a critical divergence: software is designing drugs and polymers at a velocity that physical labs and manufacturing plants cannot match.